|
GTF2H4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.960870E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.01570000002427E-06 |
| Normal-vs-Stage2 |
8.511000E-01 |
| Normal-vs-Stage3 |
6.742000E-01 |
| Normal-vs-Stage4 |
3.185800E-01 |
| Stage1-vs-Stage2 |
4.144100E-03 |
| Stage1-vs-Stage3 |
1.016550E-03 |
| Stage1-vs-Stage4 |
2.769800E-02 |
| Stage2-vs-Stage3 |
6.475200E-01 |
| Stage2-vs-Stage4 |
3.869800E-01 |
| Stage3-vs-Stage4 |
5.607800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.123600E-02 |
| Normal-vs-AfricanAmerican |
2.801600E-04 |
| Normal-vs-Asian |
2.192000E-02 |
| Caucasian-vs-AfricanAmerican |
3.603300E-03 |
| Caucasian-vs-Asian |
1.298000E-02 |
| AfricanAmerican-vs-Asian |
5.154600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.335400E-01 |
| Normal-vs-Female |
2.8815999997267E-07 |
| Male-vs-Female |
2.36789999999987E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.311600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.402400E-04 |
| Normal-vs-Age(61-80Yrs) |
4.335700E-02 |
| Normal-vs-Age(81-100Yrs) |
5.835600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.908600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.331800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.005400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.599440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.925600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.517200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.3779645747245E-12 |
| Normal-vs-Grade 2 |
2.00819999999213E-05 |
| Normal-vs-Grade 3 |
7.725600E-02 |
| Normal-vs-Grade 4 |
1.207970E-01 |
| Grade 1-vs-Grade 2 |
2.004700E-04 |
| Grade 1-vs-Grade 3 |
2.11209999999573E-05 |
| Grade 1-vs-Grade 4 |
3.7384000006746E-08 |
| Grade 2-vs-Grade 3 |
9.179900E-03 |
| Grade 2-vs-Grade 4 |
1.81320000003371E-06 |
| Grade 3-vs-Grade 4 |
6.043500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.03109999999896E-07 |
| Normal-vs-ccB subtype |
3.650800E-01 |
| ccA subtype-vs-ccB subtype |
4.9123000001039E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.584700E-03 |
| Normal-vs-N1 |
3.080400E-01 |
| N0-vs-N1 |
7.889600E-02 |
|
|
